225 related articles for article (PubMed ID: 9557515)
1. Autologous bone marrow transplantation in chronic myeloid leukaemia.
Divya
Natl Med J India; 1998; 11(1):19-21. PubMed ID: 9557515
[No Abstract] [Full Text] [Related]
2. [Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia].
Boqué C; Grañena A
Sangre (Barc); 1998 Apr; 43(2):155-63. PubMed ID: 9656777
[No Abstract] [Full Text] [Related]
3. Collection of Ph-negative progenitor cells from Ph+ CML patients in complete cytogenetic remission after long-term interferon-alpha therapy.
Russo D; Martinelli G; Montefusco V; Amabile M; Rosti G; Marin L
Haematologica; 1999 Oct; 84(10):953-5. PubMed ID: 10509048
[No Abstract] [Full Text] [Related]
4. [Mobilization of Ph-negative hematopoietic stem cells using rhG-CSF in patients with chronic myeloid leukemia treated with interferon-alfa. Experience of the Clinic Hospital of Barcelona].
Carreras E
Sangre (Barc); 1997 Apr; 42 Suppl 1():24-6. PubMed ID: 9381296
[No Abstract] [Full Text] [Related]
5. Collection of peripheral blood stem cells after a preceding autograft: unfavorable effect of prior interferon-alpha therapy.
Singhal S; Mehta J; Desikan K; Siegel D; Singh J; Munshi N; Spoon D; Anaissie E; Ayers D; Barlogie B
Bone Marrow Transplant; 1999 Jul; 24(1):13-7. PubMed ID: 10435728
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte colony-stimulating factor given in addition to interferon-alpha to mobilize peripheral blood stem cells for autologous transplantation in chronic myeloid leukaemia.
Archimbaud E; Michallet M; Philip I; Charrin C; Clapisson G; Belhabri A; Guilhot F; Stryckmans P; Adeleine P; Fière D
Br J Haematol; 1997 Dec; 99(3):678-84. PubMed ID: 9401084
[TBL] [Abstract][Full Text] [Related]
7. Autografting for CML--overview and perspectives.
Goldman JM
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S71-4. PubMed ID: 8769708
[No Abstract] [Full Text] [Related]
8. [Autologous transplantation of peripheral stem cells in patients with chronic myeloid leukemia after mobilization with high-dose hydroxyurea].
Ojeda Gutiérrez E; Arrieta Gallastegui R; Bustos JG; Pérez Piño T; Rocha R; Sánchez Godoy P; Lozano M; Bello López JL; Hernández Navarro F
Sangre (Barc); 1997 Apr; 42 Suppl 1():21-3. PubMed ID: 9381295
[No Abstract] [Full Text] [Related]
9. Unsuccessful allogeneic and autologous transplants after prolonged interferon-alpha treatment in a pediatric patient with chronic myeloid leukemia.
Pérez-Caballero C; Maldonado MS; Tamariz R; de Oteyza JP; Muñoz A
Haematologica; 2000 Jan; 85(1):105-6. PubMed ID: 10629605
[No Abstract] [Full Text] [Related]
10. Cyclophosphamide/GM-CSF priming in autotransplant therapy for CML.
McGlave P; Bhatia R; Verfaillie C
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S65-6. PubMed ID: 8769706
[No Abstract] [Full Text] [Related]
11. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
[TBL] [Abstract][Full Text] [Related]
12. [Interferon treatment in chronic myeloid leukemia].
Simonsson B
Nord Med; 1992; 107(3):76-7, 79. PubMed ID: 1549456
[TBL] [Abstract][Full Text] [Related]
13. Collection of Ph-negative progenitor cells from interferon responsive patients with chronic myeloid leukemia: effect of granulocyte-colony-stimulating factor mobilization.
Olavarria E; Parker S; Craddock C; Philpott N; Tiniakou M; Chase A; Kanfer E; Apperley JF; Goldman JM
Haematologica; 2000 Jun; 85(6):647-52. PubMed ID: 10870123
[TBL] [Abstract][Full Text] [Related]
14. [Interferon alpha in the treatment of chronic myeloid leukemia. Promises, realities, and perspectives].
Steegmann JL; Granados E; Rodríguez-Salvanés F; Casado LF; Giraldo P; Lavilla E; Gómez-Casares MT; Fernández-Contreras E; Odriozola J
Sangre (Barc); 1998 Apr; 43(2):137-46. PubMed ID: 9656775
[No Abstract] [Full Text] [Related]
15. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
16. Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood.
Dahl E; Burroughs J; DeFor T; Verfaillie C; Weisdorf D
Bone Marrow Transplant; 2003 Sep; 32(6):575-80. PubMed ID: 12953129
[TBL] [Abstract][Full Text] [Related]
17. Chronic myeloid leukemia.
Sawyers CL
N Engl J Med; 1999 Apr; 340(17):1330-40. PubMed ID: 10219069
[No Abstract] [Full Text] [Related]
18. Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion for recurrent chronic myeloid leukemia after bone marrow transplantation.
Flowers ME; Leisenring W; Beach K; Riddell S; Radich JP; Higano CS; Rowley SD; Chauncey TR; Sanders JE; Anasetti C; Storb R; Wade J; Appelbaum FR; Martin P
Biol Blood Marrow Transplant; 2000; 6(3A):321-6. PubMed ID: 10905769
[TBL] [Abstract][Full Text] [Related]
19. Autotransplantation in chronic myeloid leukemia.
Aguado MJ; Hernandez-Navarro F; Bello JL; Ojeda E; de Bustos JG; Arrieta R
Bone Marrow Transplant; 1998 Oct; 22(8):831. PubMed ID: 9827987
[No Abstract] [Full Text] [Related]
20. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction.
Atta J; Fauth F; Keyser M; Petershofen E; Weber C; Lippok G; Hoelzer D; Martin H
Bone Marrow Transplant; 2000 Jan; 25(1):97-104. PubMed ID: 10654022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]